Literature DB >> 21685264

Prolonged QT interval and lipid alterations beyond β-oxidation in very long-chain acyl-CoA dehydrogenase null mouse hearts.

Roselle Gélinas1, Julie Thompson-Legault, Bertrand Bouchard, Caroline Daneault, Asmaa Mansour, Marc-Antoine Gillis, Guy Charron, Victor Gavino, François Labarthe, Christine Des Rosiers.   

Abstract

Patients with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency frequently present cardiomyopathy and heartbeat disorders. However, the underlying factors, which may be of cardiac or extra cardiac origins, remain to be elucidated. In this study, we tested for metabolic and functional alterations in the heart from 3- and 7-mo-old VLCAD null mice and their littermate counterparts, using validated experimental paradigms, namely, 1) ex vivo perfusion in working mode, with concomitant evaluation of myocardial contractility and metabolic fluxes using (13)C-labeled substrates under various conditions; as well as 2) in vivo targeted lipidomics, gene expression analysis as well as electrocardiogram monitoring by telemetry in mice fed various diets. Unexpectedly, when perfused ex vivo, working VLCAD null mouse hearts maintained values similar to those of the controls for functional parameters and for the contribution of exogenous palmitate to β-oxidation (energy production), even at high palmitate concentration (1 mM) and increased energy demand (with 1 μM epinephrine) or after fasting. However, in vivo, these hearts displayed a prolonged rate-corrected QT (QTc) interval under all conditions examined, as well as the following lipid alterations: 1) age- and condition-dependent accumulation of triglycerides, and 2) 20% lower docosahexaenoic acid (an omega-3 polyunsaturated fatty acid) in membrane phospholipids. The latter was independent of liver but affected by feeding a diet enriched in saturated fat (exacerbated) or fish oil (attenuated). Our finding of a longer QTc interval in VLCAD null mice appears to be most relevant given that such condition increases the risk of sudden cardiac death.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21685264      PMCID: PMC3191095          DOI: 10.1152/ajpheart.01275.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  62 in total

1.  Polymorphic ventricular tachycardia and abnormal Ca2+ handling in very-long-chain acyl-CoA dehydrogenase null mice.

Authors:  Andreas A Werdich; Franz Baudenbacher; Igor Dzhura; Loice H Jeyakumar; Prince J Kannankeril; Sidney Fleischer; Alison LeGrone; Dejan Milatovic; Michael Aschner; Arnold W Strauss; Mark E Anderson; Vernat J Exil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-05       Impact factor: 4.733

2.  Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice.

Authors:  Ute Spiekerkoetter; Chonan Tokunaga; Udo Wendel; Ertan Mayatepek; Lodewijk Ijlst; Frederic M Vaz; Naomi van Vlies; Henk Overmars; Marinus Duran; Frits A Wijburg; Ronald J Wanders; Arnold W Strauss
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

3.  Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.

Authors:  K B Cox; D A Hamm; D S Millington; D Matern; J Vockley; P Rinaldo; C A Pinkert; W J Rhead; J R Lindsey; P A Wood
Journal:  Hum Mol Genet       Date:  2001-09-15       Impact factor: 6.150

4.  Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients.

Authors:  C Vianey-Saban; P Divry; M Brivet; M Nada; M T Zabot; M Mathieu; C Roe
Journal:  Clin Chim Acta       Date:  1998-01-12       Impact factor: 3.786

5.  Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.

Authors:  Eric S Goetzman; Liqun Tian; Philip A Wood
Journal:  Mol Genet Metab       Date:  2004-11-11       Impact factor: 4.797

6.  Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death.

Authors:  A Mathur; H F Sims; D Gopalakrishnan; B Gibson; P Rinaldo; J Vockley; G Hug; A W Strauss
Journal:  Circulation       Date:  1999-03-16       Impact factor: 29.690

7.  Human acyl-CoA dehydrogenase-9 plays a novel role in the mitochondrial beta-oxidation of unsaturated fatty acids.

Authors:  Regina Ensenauer; Miao He; Jan-Marie Willard; Eric S Goetzman; Thomas J Corydon; Brian B Vandahl; Al-Walid Mohsen; Grazia Isaya; Jerry Vockley
Journal:  J Biol Chem       Date:  2005-07-14       Impact factor: 5.157

8.  A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase.

Authors:  T Aoyama; Y Uchida; R I Kelley; M Marble; K Hofman; J H Tonsgard; W J Rhead; T Hashimoto
Journal:  Biochem Biophys Res Commun       Date:  1993-03-31       Impact factor: 3.575

9.  Cyclic GMP signaling in cardiomyocytes modulates fatty acid trafficking and prevents triglyceride accumulation.

Authors:  Ramzi J Khairallah; Maya Khairallah; Roselle Gélinas; Bertrand Bouchard; Martin E Young; Bruce G Allen; Gary D Lopaschuk; Christian F Deschepper; Christine Des Rosiers
Journal:  J Mol Cell Cardiol       Date:  2008-05-27       Impact factor: 5.000

10.  Autophagy regulates adipose mass and differentiation in mice.

Authors:  Rajat Singh; Youqing Xiang; Yongjun Wang; Kiran Baikati; Ana Maria Cuervo; Yen K Luu; Yan Tang; Jeffrey E Pessin; Gary J Schwartz; Mark J Czaja
Journal:  J Clin Invest       Date:  2009-10-12       Impact factor: 14.808

View more
  20 in total

1.  The Association of Polyunsaturated Fatty Acid δ-5-Desaturase Activity with Risk Factors for Type 2 Diabetes Is Dependent on Plasma ApoB-Lipoproteins in Overweight and Obese Adults.

Authors:  Valérie Lamantia; Simon Bissonnette; Viviane Provost; Marie Devaux; Yannick Cyr; Caroline Daneault; Christine Des Rosiers; May Faraj
Journal:  J Nutr       Date:  2019-01-01       Impact factor: 4.798

2.  Dampened Mesolimbic Dopamine Function and Signaling by Saturated but not Monounsaturated Dietary Lipids.

Authors:  Cecile Hryhorczuk; Marc Florea; Demetra Rodaros; Isabelle Poirier; Caroline Daneault; Christine Des Rosiers; Andreas Arvanitogiannis; Thierry Alquier; Stephanie Fulton
Journal:  Neuropsychopharmacology       Date:  2015-07-14       Impact factor: 7.853

3.  Acadl-SNP based genotyping assay for long-chain acyl-CoA dehydrogenase deficient mice.

Authors:  Rita J Luther; Alvin J O Almodovar; Russell Fullerton; Philip A Wood
Journal:  Mol Genet Metab       Date:  2012-02-15       Impact factor: 4.797

4.  Docosahexaenoic acid supplementation alters key properties of cardiac mitochondria and modestly attenuates development of left ventricular dysfunction in pressure overload-induced heart failure.

Authors:  Erinne R Dabkowski; Kelly A O'Connell; Wenhong Xu; Rogerio F Ribeiro; Peter A Hecker; Kadambari Chandra Shekar; Caroline Daneault; Christine Des Rosiers; William C Stanley
Journal:  Cardiovasc Drugs Ther       Date:  2013-12       Impact factor: 3.727

5.  High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects.

Authors:  Tatiana F Galvao; Bethany H Brown; Peter A Hecker; Kelly A O'Connell; Karen M O'Shea; Hani N Sabbah; Sharad Rastogi; Caroline Daneault; Christine Des Rosiers; William C Stanley
Journal:  Cardiovasc Res       Date:  2011-09-29       Impact factor: 10.787

6.  Follow-up of fatty acid β-oxidation disorders in expanded newborn screening era.

Authors:  Patrícia Janeiro; Rita Jotta; Ruben Ramos; Cristina Florindo; Fátima V Ventura; Laura Vilarinho; Isabel Tavares de Almeida; Ana Gaspar
Journal:  Eur J Pediatr       Date:  2019-01-07       Impact factor: 3.183

7.  Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.

Authors:  Dingding Xiong; Huamei He; Jeanne James; Chonan Tokunaga; Corey Powers; Yan Huang; Hanna Osinska; Jeffrey A Towbin; Enkhsaikhan Purevjav; James A Balschi; Sabzali Javadov; Francis X McGowan; Arnold W Strauss; Zaza Khuchua
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

8.  Metabolic effects of glutamine on the heart: anaplerosis versus the hexosamine biosynthetic pathway.

Authors:  Benjamin Lauzier; Fanny Vaillant; Clemence Merlen; Roselle Gélinas; Bertrand Bouchard; Marie-Eve Rivard; Francois Labarthe; Vern W Dolinsky; Jason R B Dyck; Bruce G Allen; John C Chatham; Christine Des Rosiers
Journal:  J Mol Cell Cardiol       Date:  2012-11-28       Impact factor: 5.000

9.  Marine n3 polyunsaturated fatty acids enhance resistance to mitochondrial permeability transition in heart failure but do not improve survival.

Authors:  Tatiana F Galvao; Ramzi J Khairallah; Erinne R Dabkowski; Bethany H Brown; Peter A Hecker; Kelly A O'Connell; Karen M O'Shea; Hani N Sabbah; Sharad Rastogi; Caroline Daneault; Christine Des Rosiers; William C Stanley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-10-26       Impact factor: 4.733

10.  Evaluation of docosahexaenoic acid in a dog model of hypertension induced left ventricular hypertrophy.

Authors:  William C Stanley; James W Cox; Girma Asemu; Kelly A O'Connell; Erinne R Dabkowski; Wenhong Xu; Rogerio F Ribeiro; Kadambari C Shekar; Stephen W Hoag; Sharad Rastogi; Hani N Sabbah; Caroline Daneault; Christine des Rosiers
Journal:  J Cardiovasc Transl Res       Date:  2013-09-25       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.